8-KItem 7.01 · Reg FD DisclosureItem 9.01 · Financial Statements

Insulet ($PODD) filed a Form 8‑K on Mar 12, 2026 furnishing a press release (Exhibit 99.1) dated Mar 12, 2026.

Filed with the SEC on March 12, 2026 · Summarized by InvestorsBot

Insulet ($PODD) filed a Form 8‑K on Mar 12, 2026 furnishing a press release (Exhibit 99.1) dated Mar 12, 2026. No other substantive Item disclosures in Item 9.01. 📢 #Insulet #8K #MedTech

The 8‑K includes an Interactive XBRL cover page (Exhibit 104) — the Inline XBRL data file was furnished with the filing. 📄 $PODD #Insulet #XBRL

The report was signed Mar 12, 2026 by John W. Kapples, SVP & General Counsel. No officer changes or additional Item 9.01 disclosures noted. ✍️ $PODD #Insulet #Corporate

Read the original filing on SEC EDGAR

Get summaries like this in your inbox every morning

Pick up to 20 companies — we read their SEC filings overnight and send you the plain-English version. Free.

Subscribe free

More from INSULET CORP

Mar 12, 2026: Insulet ($PODD) says voluntary medical-device correction; expects up to $40M of costs, all…

8-K · March 12, 2026

Insulet ($PODD) on Feb 27, 2026 entered a severance agreement with former CFO Ana M.

8-K · March 4, 2026

Insulet ($PODD) filed an 8‑K on Feb 18, 2026 furnishing a press release as Exhibit 99.1.

8-K · February 18, 2026

On Feb 13, 2026 Insulet's Board approved a $350M increase to the prior $125M share repurchase…

8-K · February 18, 2026

Insulet ($PODD) announced Q4 & full-year 2025 financial results on Feb 18, 2026 covering the period ended…

8-K · February 18, 2026

Insulet filed an Addendum (Exhibit 10.1) effective Jan 1, 2026 to its Purchase Agreement with NXP USA, Inc.

8-K · February 3, 2026